<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>23706272</identifier>
<setSpec>1578-2190</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Alsina, M</dc:author>
<dc:author>Pigem, R</dc:author>
<dc:author>Mu√±oz-Santos, C</dc:author>
<dc:description xml:lang="en">Human papillomavirus infection is very common. In this article, we review the latest developments in the treatment of lesions caused by this virus, with a particular focus on anogenital warts. Sinecatechins and new imiquimod formulations are among the most significant new developments. Others include photodynamic therapy and intralesional immunotherapy, but there is insufficient evidence to recommend their routine use. Finally, while therapeutic vaccines and inhibitory molecules appear to hold great promise, they are still in the early phases of investigation. More studies are needed, and these should have similar designs, larger samples, and sufficiently long follow-up periods to enable the direct comparison of the short-term and long-term effectiveness of different treatment options.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Warts</dc:subject>
<dc:subject>Virus del papiloma humano</dc:subject>
<dc:subject>Human papillomavirus</dc:subject>
<dc:subject>Verrugas</dc:subject>
<dc:subject>Vacunas</dc:subject>
<dc:subject>Imiquimod</dc:subject>
<dc:subject>Condilomas acuminados</dc:subject>
<dc:subject>Sinecatequinas</dc:subject>
<dc:subject>Vaccines</dc:subject>
<dc:subject>Genital Warts, Sinecatechins</dc:subject>
<dc:date>2013 Dec </dc:date>
<dc:title xml:lang="en">New treatments for human papillomavirus infection.</dc:title>
<dc:publisher>Actas dermo-sifiliograficas</dc:publisher>
</metadata>
</record>
</pubmed-document>
